November 2008 - Page 60 of 76

MondayNov 03, 2008 4:57 am

Prana Biotechnology Ltd. (NASDAQ: PRAN)

Prana Biotechnology Ltd. (NASDAQ: PRAN) has developed a proprietary portfolio of class-leading chemical compounds. The company combines this portfolio of compounds with a drug development program to discover novel therapeutics in multiple disease indications. Prana’s focus is currently on meeting the needs of patients diagnosed with neurological diseases, particularly Alzheimer‘s, Parkinson‘s and Huntington‘s diseases. For further information, visit the Company's web site at www.pranabio.com.

MondayNov 03, 2008 4:57 am

Cavico Corp. (OTC BB: CVIC)

Cavico Corp. (OTC BB: CVIC), a major infrastructure construction, infrastructure investment and natural resources conglomerate headquartered in Hanoi, Vietnam, is focused on large infrastructure projects, which include the construction of hydropower facilities, dams, bridges, tunnels, roads, mines and urban buildings. Cavico’s project partners include top multi-national corporations and government organizations. For further information, visit the Company's web site at www.cavicocorp.com.

MondayNov 03, 2008 4:57 am

Poniard Pharmaceuticals, Inc. (NASDAQ: PARD)

Poniard Pharmaceuticals, Inc. (NASDAQ: PARD), a biopharmaceutical company, has their focus on developing and commercializing novel oncology products designed to impact the lives of people with cancer. Currently, the company’s development efforts are focused on picoplatin, a new generation of platinum chemotherapy agent that could potentially become a platform product. Poniard is studying this potential platform product in a number of cancer indications, combinations and formulations. For further information, visit the Company's web site at www.poniard.com.

MondayNov 03, 2008 4:57 am

Catalyst Pharmaceutical Partners, Inc. (NASDAQ: CPRX)

Catalyst Pharmaceutical Partners, Inc. (NASDAQ: CPRX), a specialty pharmaceutical company, is focused on developing and commercializing prescription drugs designed to treat drug addiction. Currently, CPP-109 is being developed to treat addiction to cocaine, methamphetamine and other addictive substances. The company’s mission is much larger than only serving their patients, as they also seek to benefit investors and the society at large. For further information, visit the Company's web site at www.catalystpharma.com.

MondayNov 03, 2008 4:56 am

Polaris Minerals Corporation (TSX: PLS CN)

Polaris Minerals Corporation (TSX: PLS CN) is solely focused on supplying construction aggregates to coastal urban markets on the western seaboard of North America. The company has targeted markets where accelerating local supply deficits and increasing road distribution costs allow marine transported aggregates to be competitive in the hub of key coastal urban markets. Polaris is led by CEO Marco Romero who has more than 28 years of experience in the mining industry. For further information, visit the Company's web site at www.polarmin.com.

MondayNov 03, 2008 4:56 am

Pluristem Therapeutics, Inc. (NASDAQ: PSTI)

Pluristem Therapeutics, Inc. (NASDAQ: PSTI), a bio-therapeutics company, has their focus on commercializing allogeneic (non-personalized) cell therapy products designed to treat a range of severe degenerative, ischemic and autoimmune disorders. Each of Pluristem’s products begin as mesenchymal stromal cells (MSCs). These cells are derived from the human placenta, an organ that has been considered medical waste after childbirth, but recognized by the company as a source of embryonic, non-controversial source of cells. For further information, visit the Company's web site at www.pluristem.com.

MondayNov 03, 2008 4:56 am

CAS Medical Systems, Inc. (NASDAQ: CASM)

CAS Medical Systems, Inc. (NASDAQ: CASM) is focused on designing and manufacturing novel, non-invasive technologies and products essential to patient care in the most challenging clinical environments. The company’s products are used by clinicians worldwide and are recognized for their highest quality. Each and every individual at CAS Medical is dedicated to demonstrating the highest standards of innovation, quality, service and performance. For further information, visit the Company's web site at www.casmed.com.

MondayNov 03, 2008 4:55 am

Platinum Australia Limited (ASX: PLA AU)

Platinum Australia Limited (ASX: PLA AU) is committed to discovering and developing Platinum Group Metal ("PGM") Projects in Australia and around the world. In South Africa, the company is developing the Smokey Hills PGM Project which is scheduled to commence production in the first half of 2008. This project consists of an open pit and underground mining operation with an onsite processing facility capable of producing ~100,000 oz 4E PGM per annum. For further information, visit the Company's web site at www.platinumaus.com.au.

MondayNov 03, 2008 4:55 am

Adeona Pharmaceuticals, Inc. AEN)

Adeona Pharmaceuticals, Inc. (AEN), a development-stage, specialty pharmaceutical company, has dedicated its efforts to developing proprietary, late-stage drug candidates designed to treat autoimmune and central nervous system (CNS) diseases. The company’s strategy is to exclusively in-license proprietary, clinical-stage drug candidates that have proven clinical efficacy for the treatment medical diseases that are as of yet unattended to. For further information, visit the Company's web site at www.adeonapharma.com.

MondayNov 03, 2008 4:54 am

Carrizo Oil & Gas, Inc. (NASDAQ: CRZO)

Carrizo Oil & Gas, Inc. (NASDAQ: CRZO), a Houston based independent energy company, focuses on the exploration, development and production of natural gas and oil. The company’s current operations are concentrated in the Barnett Shale area of North Texas and the U.K. North Sea where two significant discoveries were made last year. Through the leveraging of a 3-D seismic database, Carrizo’s staff is continually adding to and refining the company’s substantial inventory of drilling locations. For further information, visit the Company's web site at www.carrizo.cc.

Site Search

Company Search

Month: November 2008

Prana Biotechnology Ltd. (NASDAQ: PRAN)

Cavico Corp. (OTC BB: CVIC)

Poniard Pharmaceuticals, Inc. (NASDAQ: PARD)

Catalyst Pharmaceutical Partners, Inc. (NASDAQ: CPRX)

Polaris Minerals Corporation (TSX: PLS CN)

Pluristem Therapeutics, Inc. (NASDAQ: PSTI)

CAS Medical Systems, Inc. (NASDAQ: CASM)

Platinum Australia Limited (ASX: PLA AU)

Adeona Pharmaceuticals, Inc. AEN)

Carrizo Oil & Gas, Inc. (NASDAQ: CRZO)

Market Basics

Newsletter Publishers

Public Companies